company background image
0LO3 logo

Veeva Systems LSE:0LO3 Stock Report

Last Price

US$237.31

Market Cap

US$38.9b

7D

1.0%

1Y

9.3%

Updated

07 Feb, 2025

Data

Company Financials +

0LO3 Stock Overview

Provides cloud-based software for the life sciences industry. More details

0LO3 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for 0LO3 from our risk checks.

My Notes

Capture your thoughts, links and company narrative

Veeva Systems Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Veeva Systems
Historical stock prices
Current Share PriceUS$237.31
52 Week HighUS$259.00
52 Week LowUS$170.54
Beta0.85
1 Month Change9.91%
3 Month Change0.59%
1 Year Change9.33%
3 Year Change4.42%
5 Year Change49.15%
Change since IPO289.22%

Recent News & Updates

Recent updates

Shareholder Returns

0LO3GB Healthcare ServicesGB Market
7D1.0%-4.9%1.0%
1Y9.3%-18.1%12.1%

Return vs Industry: 0LO3 exceeded the UK Healthcare Services industry which returned -18.1% over the past year.

Return vs Market: 0LO3 underperformed the UK Market which returned 12.1% over the past year.

Price Volatility

Is 0LO3's price volatile compared to industry and market?
0LO3 volatility
0LO3 Average Weekly Movement5.3%
Healthcare Services Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.7%

Stable Share Price: 0LO3 has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0LO3's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20077,172Peter Gassnerwww.veeva.com

Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process.

Veeva Systems Inc. Fundamentals Summary

How do Veeva Systems's earnings and revenue compare to its market cap?
0LO3 fundamental statistics
Market capUS$38.87b
Earnings (TTM)US$665.91m
Revenue (TTM)US$2.66b

57.8x

P/E Ratio

14.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0LO3 income statement (TTM)
RevenueUS$2.66b
Cost of RevenueUS$692.57m
Gross ProfitUS$1.96b
Other ExpensesUS$1.30b
EarningsUS$665.91m

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)4.10
Gross Margin73.93%
Net Profit Margin25.07%
Debt/Equity Ratio0%

How did 0LO3 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 01:29
End of Day Share Price 2025/02/07 00:00
Earnings2024/10/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Veeva Systems Inc. is covered by 49 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Joseph VruwinkBaird
Ishan MajumdarBaptista Research
Saket KaliaBarclays